hematopoietic stem cell transplant

The new Duke Blood Cancer Center opens up the opportunity to transition some cancer treatments from the inpatient to the outpatient setting and the infusion room is open every day.

The Duke Cancer Institute Virtual Grand Rounds Series, came to a successful summer close with its final session on June 19.

Lawrence A. David, PhD, and Anthony D. Sung, MD, named recipients of the Damon Runyon-Rachleff Innovation Award for project to personalize pre-biotic treatments for HCT patients.